60 Degrees Pharmaceuticals partners with University of Southern Mississippi to evaluate castanospermine

SXTP•2026-10-28

60 Degrees Pharmaceuticals announced a partnership with the University of Southern Mississippi to evaluate castanospermine in nonclinical models of alpha-gal syndrome.

1. Research partnership

The partnership will evaluate castanospermine in nonclinical models of alpha-gal syndrome.

60 Degrees Pharmaceuticals partners with University of Southern Mississippi to evaluate castanospermine

1. Research partnership

Related News

Nasdaq trade halt: volatility trading pause at 9:34 a.m.

US apartment vacancy rate falls to 7.8% in Q3, CoStar report shows

European benchmark gas price touches €100 for first time since December 2022

UK's Healey says government will fill gap in defence plan by 'reprioritising'

Needham cuts Geron target price to $2.5 from $4